Rural Emergency Room Simulation Teaching and Education Resource
The Power Point below discusses the assessment and management of the patient presenting with undifferentiated shock/hypotension.
The main 'message' is that these patients need diagnostic and resuscitative measures carried out simultaneously.
Having a 'mental framework' to approach such patients is critical.
Even patients presenting with a 'history' as provided by family or EHS may not be the actual reason they are hypotensive.
It is imperative that all hypotensive patients, regardless of the story have a methodical and focused approach.
Size : 4014.393 Kb
Type : pptx
Undifferentiated Shock Handout.doc
Size : 25.5 Kb
Type : doc
Tranexamic Acid (TXA):
The result of the CRASH 2 trial (2013) showed that given Tranexamic acid (TXA) within 3 hours of hemorrhage, significantly reduced death from hemorrhage.
As a result of the CRASH 2 trial, TXA has now been added to the WHO list of essential medications.
The dose is 1000 mg over 10 minutes followed by 1000 mg over the next 8 hours.
For a copy of the CRASH 2 trial, here is a LINK.
Below is a Power Point by the CRASH 2 authors.
Size : 2172.621 Kb
Type : pptx
For a review, below is a 17 minute You Tube video on the eFAST exam.